Detalles de la búsqueda
1.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37736808
2.
High-Dose Rate Brachytherapy Combined with PD-1 Blockade as a Treatment for Metastatic Adrenocortical Carcinoma - A Single Center Case Series.
Horm Metab Res
; 56(1): 30-37, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748508
3.
Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating.
Strahlenther Onkol
; 199(6): 544-553, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151215
4.
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
Strahlenther Onkol
; 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975883
5.
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
Eur J Nucl Med Mol Imaging
; 50(8): 2466-2476, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951991
6.
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 50(9): 2751-2766, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079128
7.
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE.
Eur J Nucl Med Mol Imaging
; 50(11): 3390-3399, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358620
8.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Eur J Nucl Med Mol Imaging
; 50(8): 2529-2536, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905411
9.
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Eur J Nucl Med Mol Imaging
; 50(8): 2537-2547, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36929180
10.
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Lancet Oncol
; 23(1): e21-e31, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973228
11.
Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections.
Lab Invest
; 102(12): 1400-1405, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045222
12.
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Mol Cancer
; 21(1): 178, 2022 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076232
13.
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.
Int J Cancer
; 150(4): 603-616, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648658
14.
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Cancer
; 128(12): 2358-2366, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417563
15.
Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.
Gastroenterology
; 161(3): 996-1010.e1, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097885
16.
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
Invest New Drugs
; 40(1): 163-171, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351518
17.
Radiotherapy in oligometastatic prostate cancer-a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO).
Strahlenther Onkol
; 198(8): 727-734, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364690
18.
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 49(4): 1417-1428, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34628521
19.
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
Eur J Nucl Med Mol Imaging
; 49(4): 1407-1416, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664091
20.
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Eur J Nucl Med Mol Imaging
; 50(1): 218-227, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35984452